{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T16:27:33Z","timestamp":1764174453351,"version":"3.37.3"},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R25CA092203"],"award-info":[{"award-number":["R25CA092203"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Deborah Kelly Center for Outcomes Research"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.ygyno.2017.10.038","type":"journal-article","created":{"date-parts":[[2017,11,8]],"date-time":"2017-11-08T19:31:56Z","timestamp":1510169516000},"page":"168-173","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Factors associated with delivery of neoadjuvant chemotherapy in women with advanced stage ovarian cancer"],"prefix":"10.1016","volume":"148","author":[{"given":"Emily","family":"Hinchcliff","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Melamed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy","family":"Bregar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth","family":"Diver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel","family":"Clemmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcela","family":"Del Carmen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John O.","family":"Schorge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Alejandro Rauh-Hain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9391","key":"10.1016\/j.ygyno.2017.10.038_bb0005","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/S0140-6736(03)14546-1","article-title":"From best evidence to best practice: effective implementation of change in patients' care","volume":"362","author":"Grol","year":"2003","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.ygyno.2017.10.038_bb0010","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1136\/qshc.2008.028043","article-title":"Effects of evidence-based clinical practice guidelines on quality of care: a systematic review","volume":"18","author":"Lugtenberg","year":"2009","journal-title":"Qual. Saf. Health Care"},{"issue":"20","key":"10.1016\/j.ygyno.2017.10.038_bb0015","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1001\/jama.286.20.2600","article-title":"Building bridges to quality","volume":"286","author":"Shaneyfelt","year":"2001","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ygyno.2017.10.038_bb0020","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ygyno.2011.03.022","article-title":"Trends in treatment of advanced epithelial ovarian cancer in the Medicare population","volume":"122","author":"Thrall","year":"2011","journal-title":"Gynecol. Oncol."},{"issue":"9","key":"10.1016\/j.ygyno.2017.10.038_bb0025","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.6004\/jnccn.2016.0122","article-title":"Ovarian cancer, version 1.2016, NCCN clinical practice guidelines in oncology","volume":"14","author":"Morgan","year":"2016","journal-title":"J. Natl. Compr. Cancer Netw."},{"issue":"1","key":"10.1016\/j.ygyno.2017.10.038_bb0030","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ygyno.2016.05.022","article-title":"Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline","volume":"143","author":"Wright","year":"2016","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2017.10.038_bb0035","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.ygyno.2016.09.002","article-title":"Trends in the use of neoadjuvant chemotherapy for advanced ovarian cancer in the United States","volume":"143","author":"Melamed","year":"2016","journal-title":"Gynecol. Oncol."},{"issue":"31","key":"10.1016\/j.ygyno.2017.10.038_bb0040","doi-asserted-by":"crossref","first-page":"7881","DOI":"10.1200\/JCO.2005.08.755","article-title":"Geographic and socioeconomic variation in the treatment of prostate cancer","volume":"23","author":"Krupski","year":"2005","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.ygyno.2017.10.038_bb0045","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/jnci\/94.5.334","article-title":"Racial and ethnic disparities in the receipt of cancer treatment","volume":"94","author":"Shavers","year":"2002","journal-title":"J. Natl. Cancer Inst."},{"issue":"8","key":"10.1016\/j.ygyno.2017.10.038_bb0050","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/jso.21173","article-title":"Using the NCDB for cancer care improvement: an introduction to available quality assessment tools","volume":"99","author":"Raval","year":"2009","journal-title":"J. Surg. Oncol."},{"year":"2000","series-title":"International Classification of Diseases for Oncology","key":"10.1016\/j.ygyno.2017.10.038_bb0055"},{"year":"2009","series-title":"AJCC Cancer Staging Manual","key":"10.1016\/j.ygyno.2017.10.038_bb0060"},{"key":"10.1016\/j.ygyno.2017.10.038_bb0065","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/S0895-4356(00)00256-0","article-title":"Development of a comorbidity index using physician claims data","volume":"53","author":"Klabunde","year":"2000","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.ygyno.2017.10.038_bb0070","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J. Chronic Dis."},{"author":"United States Census Bureau","key":"10.1016\/j.ygyno.2017.10.038_bb0075"},{"author":"United States Department of Agriculture Economic Research Service","key":"10.1016\/j.ygyno.2017.10.038_bb0080"},{"issue":"5","key":"10.1016\/j.ygyno.2017.10.038_bb0085","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.urology.2015.06.057","article-title":"Nonclinical factors predict selection of initial observation for renal cell carcinoma","volume":"86","author":"Maurice","year":"2015","journal-title":"Urology"},{"issue":"2","key":"10.1016\/j.ygyno.2017.10.038_bb0090","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.jamcollsurg.2015.03.056","article-title":"Nonclinical factors associated with 30-day mortality after lung cancer resection: an analysis of 215,000 patients using the National Cancer Data Base","volume":"221","author":"Melvan","year":"2015","journal-title":"J. Am. Coll. Surg."},{"issue":"5","key":"10.1016\/j.ygyno.2017.10.038_bb0095","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jamcollsurg.2013.07.007","article-title":"Referral patterns and treatment choices for patients with hepatocellular carcinoma: a United States population-based study","volume":"217","author":"Hyder","year":"2013","journal-title":"J. Am. Coll. Surg."},{"issue":"9990","key":"10.1016\/j.ygyno.2017.10.038_bb0100","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0140-6736(14)62223-6","article-title":"Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial","volume":"386","author":"Kehoe","year":"2015","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.ygyno.2017.10.038_bb0105","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1056\/NEJMoa0908806","article-title":"European Organization for Research and Treatment of Cancer-Gynaecological Cancer Group; NCIC Clinical Trials Group. Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer","volume":"363","author":"Vergote","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.ygyno.2017.10.038_bb0110","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ygyno.2011.08.014","article-title":"An analysis of patients with bulky advanced stage ovarian, tubal, and peritoneal carcinoma treated with primary debulking surgery (PDS) during an identical time period as the randomized EORTC-NCIC trial of PDS vs neoadjuvant chemotherapy (NACT)","volume":"124","author":"Chi","year":"2012","journal-title":"Gynecol. Oncol."},{"issue":"8","key":"10.1016\/j.ygyno.2017.10.038_bb0115","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1200\/JCO.2014.56.3106","article-title":"Does aggressive surgery improve outcomes? Interaction between preoperative disease burden and complex surgery in patients with advanced-stage ovarian cancer: an analysis of GOG 182","volume":"33","author":"Horowitz","year":"2015","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2017.10.038_bb0120","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1001\/jamaoncol.2016.4411","article-title":"Overall survival following neoadjuvant chemotherapy vs primary cytoreductive surgery in women with epithelial ovarian cancer","volume":"3","author":"Rauh-Hain","year":"2017","journal-title":"JAMA Oncol."},{"issue":"4","key":"10.1016\/j.ygyno.2017.10.038_bb0125","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/IGC.0000000000000967","article-title":"Factors predicting use of neoadjuvant chemotherapy compared with primary debulking surgery in advanced stage ovarian cancer-a National Cancer Database Study","volume":"27","author":"Leiserowitz","year":"2017","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"5","key":"10.1016\/j.ygyno.2017.10.038_bb0130","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1177\/1090198110382502","article-title":"An investigation into the social context of low-income, urban Black and Latina women: implications for adherence to recommended health behaviors","volume":"38","author":"Shelton","year":"2011","journal-title":"Health Educ. Behav."},{"issue":"1","key":"10.1016\/j.ygyno.2017.10.038_bb0135","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jogc.2016.09.075","article-title":"Care delivery patterns, processes, and outcomes for primary ovarian cancer surgery: a population-based review using a National Administrative Database","volume":"39","author":"Shakeel","year":"2017","journal-title":"J. Obstet. Gynaecol. Can."},{"issue":"2","key":"10.1016\/j.ygyno.2017.10.038_bb0140","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ygyno.2016.05.025","article-title":"Centralized primary care of advanced ovarian cancer improves complete cytoreduction and survival - a population-based cohort study","volume":"142","author":"Dahm-K\u00e4hler","year":"2016","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2017.10.038_bb0145","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1093\/jnci\/djt065","article-title":"Disparities in ovarian cancer care quality and survival according to race and socioeconomic status","volume":"105","author":"Bristow","year":"2013","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ygyno.2017.10.038_bb0150","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ygyno.2014.10.023","article-title":"Ovarian cancer in the United States: contemporary patterns of care associated with improved survival","volume":"136","author":"Cliby","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2017.10.038_bb0155","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1097\/AOG.0000000000000643","article-title":"Sociodemographic disparities in advanced ovarian cancer survival and adherence to treatment guidelines","volume":"125","author":"Bristow","year":"2015","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2017.10.038_bb0160","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.1200\/JCO.2014.55.6258","article-title":"Disparities in stage at diagnosis, treatment, and survival in nonelderly adult cancer patients according to insurance status","volume":"32","author":"Walker","year":"2014","journal-title":"J. Clin. Oncol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825817314609?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825817314609?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T08:45:20Z","timestamp":1565340320000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825817314609"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S0090825817314609"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2017.10.038","relation":{},"ISSN":["0090-8258"],"issn-type":[{"type":"print","value":"0090-8258"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Factors associated with delivery of neoadjuvant chemotherapy in women with advanced stage ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2017.10.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}